Christina Mattina

With the comment period now concluded, CMS has received nearly 1300 comments on its proposed amendments to the Quality Payment Program established by the Medicare Access and CHIP Reauthorization Act (MACRA).

A new study indicates that expanded coverage under the Affordable Care Act (ACA) added strain on emergency medical services, resulting in slower ambulance response times.

A reference pricing initiative was linked to more prescription fills of lowest-priced drugs and a decreased average price per prescription, but higher rates of copayments by patients, a new study finds.

A CDC study asked adolescents and adults about their contact lens practices and found that most reported engaging in at least 1 risky behavior.

As observers across the United States prepare to witness a rare solar eclipse this afternoon, ophthalmologists are making sure the importance of vision safety is not overshadowed by the excitement.

A new study in the American Journal of Public Health finds that rates of suicide by firearm were more common than non-firearm suicides in the most rural areas.

A small phase 1b trial of pembrolizumab in patients with small-cell lung cancer shows that the immunotherapy drug had a favorable safety profile and demonstrated “promising” antitumor activity.

A letter from CMS lays out 2 options for New Hampshire: either stop accepting donations from hospitals to fund Medicaid expansion or have the program’s federal funding revoked.

Following completion of their chemotherapy regimen, many women who have survived cancer experience lingering symptoms of chemotherapy-induced peripheral neuropathy, according to a new study.

As HHS celebrates National Health Center Week by announcing $105 million in grants for quality improvement, a study indicates that practice transformation may be taking a toll on satisfaction among clinicians and staff at some federally qualified health centers.

An analysis by Kaiser Health News found that Medicaid incurred billions of dollars in extra spending as a result of price increases for hundreds of common drugs from 2015 to 2016, including decades-old branded drugs and generics used to treat cancer.

A pair of articles published in JAMA examined the quality of studies used by the FDA to support its accelerated approval decisions and high-risk device modification approvals.

A new study indicates there are persistent socioeconomic disparities in the rates of women who receive breast reconstruction surgery after undergoing a mastectomy to treat their breast cancer.

The specialty access standards adopted by some state Medicaid programs have not had the desired outcome of making specialty care more accessible for beneficiaries who seek such care, a new study finds.

Patients discharged from hospitals may not be fully equipped with the information they need to select a high-quality skilled nursing facility (SNF), according to a new study.

New research indicates that veterans who played a diabetes education game in teams demonstrated greater improvements in blood glucose control than veterans who learned about diabetes management from a booklet.

A new report from the Kaiser Family Foundation examines preliminary data on premium rates and plan offerings on the Affordable Care Act’s exchanges.

MimiVax announced that its immunotherapy vaccine SurVaxM, which is being tested in clinical trials for glioblastoma, has been designated an orphan drug by the FDA.

Researchers have highlighted physician education as a potential solution for the opioid epidemic, based on their findings that attending a top-ranked medical school is associated with writing far fewer opioid prescriptions.

New research has identified a gene that enables paclitaxel to spread cancer to the lungs even as it shrinks tumors in the breast.

A new study indicates that drugs approved through the FDA’s expedited review programs offer larger health gains than those approved via the traditional review process.

Amidst news of Senator John McCain’s glioblastoma diagnosis, a recent discussion between 2 neuro-oncology researchers explored the reasons why this aggressive brain tumor is so difficult to manage, and outlined the ongoing investigations into possible therapies.

A recent study described why physicians find that deprescribing a patient's ongoing medication may be easier said than done.

In an effort to brainstorm strategies that will boost patient engagement in medical device development, the FDA has announced it will host the first meeting of its Patient Engagement Advisory Committee this fall.

After the Affordable Care Act (ACA) required private insurers to pay the standard-of-care costs for patients participating in approved clinical trials, the rate of patients cleared by their insurer to take part in early-phase oncology trials has increased, a new study has found.

According to a recent study, implementing cost sharing requirements on mental health services produced short-term savings by reducing mental health care use, but resulted in more costly outcomes like involuntary commitment and acute mental health treatment.

A survey designed to assess knowledge of prediabetes among primary care providers (PCPs) finds that their awareness of risk factors and management strategies is lower than ideal.

With Republicans unable to agree on legislation to repeal and replace the Affordable Care Act (ACA), the next step may be to work out some bipartisan fixes with Democrats. Here are 5 ideas that could appear in a bipartisan deal to fix the ACA.

When Donald Trump was elected president in November 2016, repealing the Affordable Care Act (ACA) suddenly became an attainable goal for Republicans in Congress. Here, we look back at the legislative twists and turns of ACA repeal efforts in 2017.

AstraZeneca announced that its immuno-oncology drug durvalumab, in combination with tremelimumab, failed to meet a progression-free survival endpoint in the MYSTIC trial in patients with metastatic non-small cell lung cancer (NSCLC).